EUR 4.45
(0.23%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 46.25 Million EUR | -22.73% |
2022 | 59.86 Million EUR | -17.68% |
2021 | 72.72 Million EUR | -21.48% |
2020 | 92.61 Million EUR | 53.95% |
2019 | 60.15 Million EUR | 19.47% |
2018 | 50.35 Million EUR | -12.03% |
2017 | 57.24 Million EUR | 0.86% |
2016 | 56.75 Million EUR | 0.36% |
2015 | 56.54 Million EUR | 1.99% |
2014 | 55.44 Million EUR | 0.97% |
2013 | 54.91 Million EUR | -0.44% |
2012 | 55.15 Million EUR | -1.8% |
2011 | 56.16 Million EUR | 1.17% |
2010 | 55.51 Million EUR | 3.38% |
2009 | 53.69 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 45.47 Million EUR | 0.0% |
2023 Q4 | 46.25 Million EUR | 0.0% |
2023 Q3 | 46.25 Million EUR | -15.39% |
2023 Q2 | 54.67 Million EUR | 0.0% |
2023 Q1 | 54.67 Million EUR | -8.67% |
2023 FY | 46.25 Million EUR | -22.73% |
2022 FY | 59.86 Million EUR | -17.68% |
2022 Q3 | 59.86 Million EUR | -7.81% |
2022 Q2 | 64.94 Million EUR | 0.0% |
2022 Q1 | 64.94 Million EUR | -10.7% |
2022 Q4 | 59.86 Million EUR | 0.0% |
2021 Q1 | 78.3 Million EUR | -15.46% |
2021 FY | 72.72 Million EUR | -21.48% |
2021 Q3 | 72.72 Million EUR | -7.13% |
2021 Q2 | 78.3 Million EUR | 0.0% |
2021 Q4 | 72.72 Million EUR | 0.0% |
2020 Q3 | 92.61 Million EUR | -14.55% |
2020 Q1 | 108.38 Million EUR | 80.16% |
2020 FY | 92.61 Million EUR | 53.95% |
2020 Q2 | 108.38 Million EUR | 0.0% |
2020 Q4 | 92.61 Million EUR | 0.0% |
2019 Q2 | 57.71 Million EUR | 0.0% |
2019 Q4 | 60.15 Million EUR | 11.45% |
2019 Q3 | 53.98 Million EUR | -6.48% |
2019 FY | 60.15 Million EUR | 19.47% |
2019 Q1 | 57.71 Million EUR | 0.0% |
2018 FY | 50.35 Million EUR | -12.03% |
2017 Q1 | 57.24 Million EUR | 2.9% |
2017 FY | 57.24 Million EUR | 0.86% |
2017 Q4 | 60.22 Million EUR | 0.0% |
2017 Q3 | 60.22 Million EUR | 5.21% |
2017 Q2 | 57.24 Million EUR | -0.0% |
2016 FY | 56.75 Million EUR | 0.36% |
2016 Q4 | 55.62 Million EUR | 0.0% |
2016 Q1 | 56.75 Million EUR | 1.64% |
2016 Q2 | 56.75 Million EUR | 0.0% |
2016 Q3 | 55.62 Million EUR | -1.98% |
2015 FY | 56.54 Million EUR | 1.99% |
2015 Q2 | 56.54 Million EUR | 0.0% |
2015 Q1 | 56.54 Million EUR | -1.88% |
2015 Q4 | 55.83 Million EUR | 0.0% |
2015 Q3 | 55.83 Million EUR | -1.26% |
2014 Q4 | 57.63 Million EUR | 0.0% |
2014 FY | 55.44 Million EUR | 0.97% |
2014 Q2 | 55.44 Million EUR | 1.22% |
2014 Q1 | 54.77 Million EUR | 3.44% |
2014 Q3 | 57.63 Million EUR | 3.94% |
2013 Q2 | 54.91 Million EUR | 0.0% |
2013 Q3 | 52.95 Million EUR | -3.57% |
2013 Q4 | 52.95 Million EUR | 0.0% |
2013 Q1 | 54.91 Million EUR | 0.42% |
2013 FY | 54.91 Million EUR | -0.44% |
2012 Q1 | 55.15 Million EUR | -0.95% |
2012 Q4 | 54.68 Million EUR | 0.0% |
2012 Q3 | 54.68 Million EUR | -0.85% |
2012 Q2 | 55.15 Million EUR | 0.0% |
2012 FY | 55.15 Million EUR | -1.8% |
2011 Q3 | 55.68 Million EUR | -0.85% |
2011 FY | 56.16 Million EUR | 1.17% |
2011 Q4 | 55.68 Million EUR | 0.0% |
2011 Q2 | 56.16 Million EUR | 0.0% |
2010 Q2 | 55.51 Million EUR | 0.0% |
2010 Q4 | 50.31 Million EUR | 0.0% |
2010 FY | 55.51 Million EUR | 3.38% |
2009 FY | 53.69 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Affluent Medical SA | 56.62 Million EUR | 18.305% |
Bluelinea Société Anonyme | 13.16 Million EUR | -251.381% |
Carmat SA | 53.06 Million EUR | 12.833% |
Diagnostic Medical Systems S.A. | 51.13 Million EUR | 9.542% |
Eurobio Scientific Société anonyme | 315.81 Million EUR | 85.353% |
Ikonisys S.A. | 20.85 Million EUR | -121.835% |
Implanet S.A. | 10.63 Million EUR | -334.882% |
Median Technologies SA | 35.81 Million EUR | -29.17% |
SpineGuard SA | 11.03 Million EUR | -319.184% |
Theraclion SA | 18.66 Million EUR | -147.854% |
Euroapi S.A. | 1.61 Billion EUR | 97.131% |
Guerbet SA | 1.02 Billion EUR | 95.488% |
Ion Beam Applications SA | 597.52 Million EUR | 92.258% |
Koninklijke Philips N.V. | 29.7 Billion EUR | 99.844% |
Sequana Medical NV | 10.1 Million EUR | -357.957% |